Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
53.50    3.50 (7.00%)
Bid:
53.00
Ask:
54.00
Spread: 1.00 (1.887%)
Market Cap: £102.64m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Directors' Disclosure

29 Nov 2013 07:00

RNS Number : 2260U
Iofina PLC
29 November 2013
 



29 November 2013

 

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Directors' Disclosure

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, announces a change in the beneficial ownership in the share capital of the Company for George Lantz, Chief Executive Officer, and Jeff Ploen, Non-Executive Deputy Chairman.

 

J. Paul Consulting, Inc. (a company in which Jeff Ploen has the sole beneficial interest) has granted to Mr Lantz 125,000 options over such number of ordinary shares in the capital of the Company held by J. Paul Consulting, Inc. with an exercise price per share of £1.51, being the closing share price on the day Mr Lantz joined the Company, with 33.3% of such options vested at grant date, and 33.3% to vest at each of 19 September 2014 at 19 September 2015.

 

Lance Baller, the former Chief Executive Officer of IOF, has granted to Mr Lantz 125,000 options over such number of ordinary shares in the capital of the Company held by Mr Baller with an exercise price per share of £1.51, being the closing share price on the day Mr Lantz joined the Company, with 33.3% of such options vested at grant date, and 33.3% to vest at each of 19 September 2014 at 19 September 2015.

 

Following the grant of options the revised holdings of Mr Lantz and Mr Ploen are set out below:

 

Director

Number of Shares

% of issued share capital

Total Number of Shares Under Option

Exercise Price

George Lantz

26,433

0.02

500,000

151p

Jeff Ploen

9,400,000*

7.39

Nil

* Includes 1,200,000 Shares held by J Paul Consulting, Inc.

 

Each of J Paul Consulting, Inc. and Lance Baller is prohibited from selling the aforementioned number of shares as are required to satisfy their undertaking to Mr Lantz. The Company is not a party to the arrangements agreed between Mr Ploen, Mr Baller and Mr Lantz respectively, both of which are private transactions agreed between them.

 

 

For further information, please contact:

 

Gary Gatchell, Finance DirectorTel: +44 (0) 20 3006 3135Simon Holden, Company SecretaryTel: +44 (0) 7800 500 097

Iofina plcwww.iofina.com 

 

Ben Colegrave/Chris Sim/James Rudd

Investec

Tel: +44(0)20 7597 5970

 

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739

 

About Iofina

 

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, California, Montana, Oklahoma and Wyoming. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUWSNROUAAUAA
Date   Source Headline
10th Apr 20129:39 amRNSHolding(s) in Company
5th Apr 20128:05 amRNSPurchase of Production Site & Recycling Initiative
2nd Apr 20125:01 pmRNSHolding(s) in Company
29th Mar 201212:11 pmRNSHolding(s) in Company
19th Mar 20127:00 amRNSCorporate Update
25th Nov 20117:00 amRNSDirector/PDMR Shareholding
24th Nov 20117:00 amRNSDirector/PDMR Shareholding
17th Oct 20117:00 amRNSHolding(s) in Company
27th Sep 20117:00 amRNSHalf Yearly Report
9th Aug 20117:00 amRNSTrading Update
30th Jun 20114:42 pmRNSResult of AGM
24th Jun 201111:42 amRNSHolding(s) in Company
8th Jun 20117:00 amRNSAmbrian Partners Appointed Joint Broker to Iofina
7th Jun 20117:00 amRNSIofina Reports Audited Full Year Financials
31st May 20116:03 pmRNSHolding(s) in Company
4th May 20114:32 pmRNSHolding(s) in Company
4th May 20114:29 pmRNSHolding(s) in Company
28th Apr 201112:58 pmRNSHolding(s) in Company
20th Apr 20117:00 amRNSPlacing
13th Apr 20116:28 pmRNSHolding(s) in Company
25th Mar 20117:00 amRNSContract Win
18th Mar 20117:00 amRNSHolding(s) in Company
1st Mar 20113:35 pmRNSHolding(s) in Company
27th Jan 20115:27 pmRNSHolding(s) in Company
12th Jan 20114:40 pmRNSSecond Price Monitoring Extn
12th Jan 20114:35 pmRNSPrice Monitoring Extension
3rd Dec 201012:46 pmRNSOperations Update
19th Oct 20105:30 pmRNSHolding(s) in Company
29th Sep 20109:26 amRNSHolding(s) in Company
28th Sep 20107:01 amRNSInterim Results
28th Sep 20107:00 amRNSAppointment of Finance Director
31st Aug 20107:00 amRNSFourth Extraction and Collection Agreement Signed
16th Jul 20105:57 pmRNSHolding in Company - Replacement
16th Jul 20105:02 pmRNSHoldings in Company
7th Jul 201010:00 amRNSResult of AGM
4th Jun 20107:00 amRNSFinal Results
20th May 20107:00 amRNSNew Agreement Signed and Operations Update
4th May 20107:00 amRNSIssuance of Permit
14th Apr 20107:00 amRNSThird Party Iodine Agreement Signed
22nd Mar 20108:36 amRNSFirst Third Party Iodine Extraction and Collection
22nd Mar 20107:00 amRNSRe Iodine Extraction and Collection Agreement
8th Mar 20107:02 amRNSOperations Update
8th Mar 20107:00 amRNSManagement changes
12th Jan 20103:09 pmRNSDirectorate Change
8th Jan 20107:00 amRNSDirector's Dealings
11th Dec 20096:00 pmRNSHolding in Company
22nd Oct 20095:14 pmRNSChange of Name of Nominated Adviser
19th Oct 20094:07 pmRNSExercise of Options
30th Sep 20097:00 amRNSHalf Yearly Report
10th Aug 200911:13 amRNSManagement Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.